Carious Tissue Selective Removal on Permanent Posterior Teeth.

Juan Gonzalo Olivieri

Status: Enrolling

Conditions: Dental Caries; Dental Materials

Treatments: Procedure: Carious tissue selective removal

Study type: Interventional

Funder types: Other

Identifiers

NCT04533113

ENDECL201804

Details and patient eligibility

About

This study is a prospective randomized controlled study of patients who come to the University. The aim is to evaluate the success rate of selective removal of carious tissue in deep lesions of posterior teeth. Three different materials will be used as liners (VitreBond ™Plus, BioDentine™, and Theracal™ LC). Post-operative pain, clinical, and radiographic success will be evaluated at one, two, and five-year follow-up. The null hypothesis is that there will be no statistically significant differences in rates of successful treatment with the three materials used.

Enrollment: 111 estimated patients

Sex: All

Ages: 18 to 75 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Patients that demonstrate understanding of the study and willingness to participate as evidenced by signing the voluntary informed consent and received a signed and dated copy of the informed consent form.
• Understands and is willing to comply with all study procedures and restrictions.
• Not presence of clinically significant and relevant abnormalities of clinical history or oral examination.
• Diagnosis of normal pulp or reversible pulpitis.
• No presence of periapical periodontitis
• Posterior teeth

Exclusion criteria

General: Patients with systemic diseases, diabetes, immunocompromised and pregnant women, or any clinically significant or relevant oral abnormalities.

Specific: Impossibility of restoration, diagnosis of irreversible pulpitis or necrosis, preoperative pain

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

111 participants in 3 patient groups

VitreBond LC

Experimental group

Description:

VitreBond LC used as a liner after selective carious tissue removal.

Treatment:

Procedure: Carious tissue selective removal

Biodentine

Experimental group

Description:

Biodentine used as a liner after selective carious tissue removal.

Treatment:

Procedure: Carious tissue selective removal

Theracal

Experimental group

Description:

Theracal used as a liner after selective carious tissue removal.

Treatment:

Procedure: Carious tissue selective removal